Skip to main content

Table 1 Distributions of horses within treatment groups

From: Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent

Treatment group

Treatment

Mean age (years)

Mean weight (kg)

Mares (n)

Geldings (n)

Stallions (n)

WBl (n)

ThB (n)

Grey (n)

Non-grey (n)

A

SAINT18

11.1

561

2

3

1

4

2

2

4

B

SAINT18+ eqIL12 + eqIL18

10.8

589

2

3

1

5

1

2

4

C

SAINT18+ eqIL12-ATG + eqIL18-ATG

10.1

548

0

5

1

4

2

2

4

D

SAINT18+ eqIL12-ATG-CG + eqIL18-ATG-CG

11.3

591

2

4

0

5

1

2

4

  1. IL interleukin, −ATG nonsense DNA, −ATC-CG nonsense DNA depleted of CG, WBl warmblood, ThB thoroughbred